Press Release
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia for up to 10 hours, a condition impacting approximately 128 million adults in the United States
Essilor Stellest is the first and only FDA market authorized spectacle lens in the...
EssilorLuxottica today announced the U.S. Food and Drug Administration (FDA) has granted market authorization for its Essilor Stellest lens using the De Novo pathway. This follows the product’s earlier recognition with the FDA granting designation as a Breakthrough Device in 2021. The Essilor Stellest lens is the first-ever FDA market authorized spectacle lens clinically proven to slow myopia progression in children1,2.
LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia
VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting approximately 128 million adults...
Oakley has officially named Travis Scott as their first-ever Chief Visionary
Today, Oakley has officially named Travis Scott as their first-ever Chief Visionary, launching a multi-year creative partnership that marks a bold new chapter for...
Transitions Announces Winners of its Optical Advancement Educational Grants
PINELLAS PARK, Fla., June , 2025 – Transitions, in partnership with its Optical AdvancementBoard, has named the recipients for its Optical Advancement Educational Grant program, whichaims to help...